SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-065128
Filing Date
2021-05-12
Accepted
2021-05-12 16:16:05
Documents
66
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2111662d1_10q.htm 10-Q 446578
2 EXHIBIT 31.1 tm2111662d1_ex31-1.htm EX-31.1 7953
3 EXHIBIT 31.2 tm2111662d1_ex31-2.htm EX-31.2 7823
4 EXHIBIT 32.1 tm2111662d1_ex32-1.htm EX-32.1 3991
5 EXHIBIT 32.2 tm2111662d1_ex32-2.htm EX-32.2 3960
  Complete submission text file 0001104659-21-065128.txt   4359889

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eyeg-20210331.xml EX-101.INS 984555
7 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20210331.xsd EX-101.SCH 43410
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20210331_cal.xml EX-101.CAL 44376
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20210331_def.xml EX-101.DEF 176545
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20210331_lab.xml EX-101.LAB 360746
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20210331_pre.xml EX-101.PRE 312172
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 21915297
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences